板塊異動 | 恆生科技指數午後小幅跳水,微盟集團一度跌超5%領跌
uSMART盈立智投1月13日消息,週三港股午後,恆生科技指數小幅跳水,截至13:38分,恆生科技指數跌超1%,30只成分股,僅10只股票飄紅,聯想集團漲超11%領漲,微盟集團一度跌超5%領跌,金蝶國際、貓眼娛樂、平安好醫生跌超3%。
2021年開局以來,恆生科技指數僅累計漲幅逾2%,小幅跑輸恆生指數,大幅跑輸滬深300指數。
個股消息方面,此前聯想集團董事會批準公司發行中國存託憑證並在科創板上市的建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.